A. Kamireddy

Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133.

H. M. Petrassi, P. McNamara, Minhua Qiu, 2020, Journal of medicinal chemistry.

AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes

R. Shaw, L. Eichner, M. Shokhirev, 2016, Genes & development.

Inhibition of DYRK1A and GSK3B induces human β-cell proliferation

Austin D. Swafford, P. McNamara, A. Herman, 2015, Nature Communications.

The AMPK-related kinases SIK1 and SIK3 mediate key tumor suppressive effects of LKB1 in NSCLC.

R. Shaw, L. Eichner, R. Svensson, 2019, Cancer discovery.

Small-molecule inducer of β cell proliferation identified by high-throughput screening.

Matthew S. Tremblay, P. Schultz, P. McNamara, 2013, Journal of the American Chemical Society.

Islet isolation from human pancreas with extended cold ischemia time.

D. Scharp, W. Kühtreiber, L. Ho, 2010, Transplantation proceedings.

A Dual Inhibitor of DYRK1A and GSK3β for β-Cell Proliferation: Aminopyrazine Derivative GNF4877.

P. McNamara, G. Harb, Shanshan Yan, 2020, ChemMedChem.